1. Home
  2. INHD vs BGLC Comparison

INHD vs BGLC Comparison

Compare INHD & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inno Holdings Inc.

INHD

Inno Holdings Inc.

HOLD

Current Price

$1.07

Market Cap

9.6M

Sector

N/A

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$2.56

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INHD
BGLC
Founded
2019
2017
Country
Hong Kong
Malaysia
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
10.1M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
INHD
BGLC
Price
$1.07
$2.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
120.3K
8.4K
Earning Date
05-01-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
17.61
45.78
EPS
N/A
N/A
Revenue
$2,846,250.00
$9,510,646.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
221.43
N/A
52 Week Low
$0.06
$0.23
52 Week High
$15.90
$15.19

Technical Indicators

Market Signals
Indicator
INHD
BGLC
Relative Strength Index (RSI) 46.91 53.66
Support Level $1.07 $2.12
Resistance Level $1.18 $2.73
Average True Range (ATR) 0.06 0.15
MACD 0.01 0.04
Stochastic Oscillator 40.54 75.01

Price Performance

Historical Comparison
INHD
BGLC

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: